Does Surgeon (Instead of Operator) Experience Affect TAVR?

There is a correlation between the volume of conventional surgical aortic valve replacement procedures and better outcomes in transcatheter aortic valve replacement (TAVR), with higher 30-day and 1-year mortality in sites with lower volume. This is a probable indication that a good surgical team is complemented by a good hemodynamic team and, ultimately, a good heart team that carefully selects which patients will be assigned to each strategy.

Experiencia de los cirujanos

Additionally, there is much evidence indicating that interventional cardiologist experience has a significant impact on outcomes. This work solidifies our understanding that the whole team’s experience (and not only individual operator experience) is important.

Researchers assessed 208,400 patients who underwent heart surgery from 2012 to 2015. Sites were classified according to the volume of surgeries during the study period. The primary endpoint was mortality at 30 days and at 1 year after TAVR.

A total of 65,757 patients underwent surgical valve replacement and 42,967 underwent TAVR. Among TAVR procedures, 21.7% (n = 9324) were performed at hospitals with <100 surgeries per year, 35.6% at sites with 100 to 199 surgeries, 22.9% at sites with 200 to 299, and 19.8% at hospitals with over 300 surgical aortic valve replacement procedures per year.


Read also: ACC 2020 Virtual | PRECOMBAT: 10 años para cirugía vs angioplastia en el tronco de la coronaria izquierda.


Mortality at 30 days was 30% higher in sites with <100 surgeries and 25% in sites with 100 to 199 surgeries, compared with sites with >300 surgeries (odds ratio [OR]: 1.32; 95% confidence interval [CI]: 1.18 to 1.47, and OR: 1.25; 95% CI: 1.12 to 1.39, respectively). The difference in relation to sites with 200 to 299 surgeries was not significant.

The aforementioned differences persisted one year after TAVR.

Conclusion

The total volume of surgical aortic valve replacement procedures at a site is well correlated with TAVR outcomes for the same site. Sites with <100 surgeries per year have the highest mortality rate with TAVR. These data support the notion that surgical programs go hand in hand with TAVR programs, and that a minimum of surgical procedures should be considered as an additional metric for TAVR outcomes.

Original title: Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes.

Reference: Sameer A. Hirji et al. J Am Coll Cardiol Intv 2020;13:335–43.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...